真实世界数据库中PSMA PET的PRIMARY评分与多参数MRI的PI-RADS对前列腺癌诊断的可重复性与准确性
本研究在242例(最终纳入227例)前列腺活检前接受68Ga-PSMA PET与多参数MRI的男性中,评估PRIMARY评分与PI-RADS的可重复性与诊断准确性。首次使用PRIMARY评分的核医学专家在二分类评估中可重复性(κ=0.70)高于经验丰富的放射科医生应用PI-RADS(κ=0.58),两种方法诊断临床显著前列腺癌的效能相似。结论认为解读前列腺内PSMA PET图像时应考虑使用PRIMARY评分。
要点
- PRIMARY评分二分类评估的观察者间可重复性κ=0.70,高于PI-RADS的κ=0.58。
- PSMA PET与mpMRI检测csPCa的敏感性86% vs 89%,特异性76% vs 74%。
- 联合影像阳性(PI-RADS 4-5或PI-RADS 1-3伴PRIMARY 3-5)敏感性94%、特异性68%。
核心结论
- 由首次使用PRIMARY评分的核医学专家应用该评分显示出较高的观察者间可重复性,超过由经验丰富mpMRI放射科医生应用的PI-RADS。
- 两种模态的诊断效能相似。
- 作者认为解读前列腺内PSMA PET图像时应考虑使用PRIMARY评分。
研究设计与样本
- 伦理批准的回顾性研究,共242例在前列腺经会阴穿刺活检前接受68Ga-PSMA PET与mpMRI的男性数据可用。
- 最终纳入227例具备组织病理学、68Ga-PSMA PET与mpMRI影像的患者。
- 6名专注于前列腺的核医学专家接受1小时培训(30幅示例图像)后应用PRIMARY评分;6名经验丰富的放射科医生按PI-RADS v2.1阅片。
- 所有图像在遮蔽临床信息下至少读取两次,不一致结果必要时发送给遮蔽的第三或第四位读者。
- 以活检国际泌尿病理学会分级组≥2(csPCa)为金标准。
主要发现
- 227例中33%无csPCa,67%有csPCa。
- 二分类(良性 vs 恶性)总体观察者间信度PRIMARY评分κ=0.70,高于PI-RADS的κ=0.58。
- 全部5类评估时PRIMARY评分κ=0.65,PI-RADS κ=0.48。
- 检测csPCa的敏感性PSMA PET 86% vs mpMRI 89%,特异性76% vs 74%,阳性预测值88% vs 88%,阴性预测值72% vs 76%。
- 联合影像阳性时敏感性94%、特异性68%、阳性预测值86%、阴性预测值85%。
关键数值与推荐
- PRIMARY评分为5类量表,基于解剖部位、模式和强度识别临床显著前列腺内恶性肿瘤。
- 联合影像阳性定义为任何PI-RADS 4或5分,或PI-RADS 1-3分伴PRIMARY 3-5分。
- 金标准为活检国际泌尿病理学会分级组≥2(csPCa)。
- 二分类可重复性评估将评分1或2归为阴性,3、4或5归为阳性。
临床怎么用
- 作者认为解读前列腺内PSMA PET图像时应考虑使用PRIMARY评分。
- PRIMARY评分需在外部数据集中评估。
局限性
- 原文指出PRIMARY评分需在外部数据集中评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The PRIMARY score is a 5-category scale developed to identify clinically significant intraprostate malignancy (csPCa) on 68Ga-prostate-specific membrane antigen (PSMA)-11 PET/CT (68Ga-PSMA PET) using a combination of anatomic site, pattern, and intensity. Developed within the PRIMARY trial, the score requires evaluation in external datasets. This study aimed to assess the reproducibility and diagnostic accuracy of the PRIMARY score in a cohort of patients who underwent multiparametric MRI (mpMRI) and 68Ga-PSMA PET before prostate biopsy for the diagnosis of prostate cancer. Methods: In total, data from 242 men who had undergone 68Ga-PSMA PET and mpMRI before transperineal prostate biopsy were available for this ethics-approved retrospective study. 68Ga-PSMA PET and mpMRI data were centrally collated in a cloud-based deidentified image database. Six experienced prostate-focused nuclear medicine specialists were trained (1 h) in applying the PRIMARY score with 30 sample images. Six radiologists experienced in prostate mpMRI read images as per the Prostate Imaging-Reporting and Data System (PI-RADS), version 2.1. All images were read (with masking of clinical information) at least twice, with discordant findings sent to a masked third (or fourth) reader as necessary. Cohen κ was determined for both imaging scales as 5 categories and then collapsed to binary (negative and positive) categories (score 1 or 2 vs. 3, 4, or 5). Diagnostic performance parameters were calculated, with an International Society of Urological Pathology grade group of at least 2 (csPCa) on biopsy defined as the gold standard. Combined-imaging-positive results were defined as any PI-RADS score of 4 or 5 or as a PI-RADS score of 1-3 with a PRIMARY score of 3-5. Results: In total, 227 patients with histopathology, 68Ga-PSMA PET, and mpMRI imaging before prostate biopsy were included; 33% had no csPCa, and 67% had csPCa. Overall interrater reliability was higher for the PRIMARY scale (κ = 0.70) than for PI-RADS (κ = 0.58) when assessed as a binary category (benign vs. malignant). This was similar for all 5 categories (κ = 0.65 vs. 0.48). Diagnostic performance to detect csPCa was comparable between PSMA PET and mpMRI (sensitivity, 86% vs. 89%; specificity, 76% vs. 74%; positive predictive value, 88% vs. 88%; negative predictive value, 72% vs. 76%). Using combined imaging, sensitivity was 94%, specificity was 68%, positive predictive value was 86%, and negative predictive value was 85%. Conclusion: The PRIMARY score applied by first-user nuclear medicine specialists showed substantial interrater reproducibility, exceeding that of PI-RADS applied by mpMRI-experienced radiologists. Diagnostic performance was similar between the 2 modalities. The PRIMARY score should be considered when interpreting intraprostatic PSMA PET images.
引用
- Emmett L, Papa N, Counter W, et al. Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database. J Nucl Med. 2024. PMID: 38050155. doi:10.2967/jnumed.123.266164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。